Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens
Allergy Explorer
MacroArray Diagnostics
Diagnosis of pollen
Dust mite
Dermatophagoides pteronyssinus
Alternaria alternata
ImmunoCAP Immuno Solid-phase Allergen Chip (ISAC)
ThermoFisher Scientific
Immuno Solid-phase Allergen Chip (ISAC)
Issue Date: 
Editorial note: 
© 2021 American College of Allergy, Asthma & Immunology
Sabaté-Brescó, M. (Marina); Quan, P.L. (Paola Leonor); D'Amelio-Garofalo, C.M. (Carmen Mariana); et al. "Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens". Annals of Allergy, Asthma & Immunology. 128 (3), 2022, 283 - 290
Background As the use of multiplex-specific immunoglobulin E (sIgE) detection methods becomes increasingly widespread, proper comparative validation assessments of emerging new platforms are vital. Objective To evaluate the clinical and technical performance of a newly introduced microarray platform, Allergy Explorer (ALEX) (MacroArray Diagnostics), in the diagnosis of pollen (cypress, grass, olive), dust mite (Dermatophagoides pteronyssinus), mold (Alternaria alternata), fruit (apple, peach), and nut (walnut, hazelnut and peanut) allergies and to compare it with those of the ImmunoCAP Immuno Solid-phase Allergen Chip (ISAC) 112 microarray and the ImmunoCAP singleplex method (ThermoFisher Scientific). Methods We enrolled 153 patients with allergy and 16 controls without atopy. The sIgE assays were conducted using ISAC112, ALEX version 2 (ALEX2), and ImmunoCAP for whole extracts and major components. Technical validation of ALEX2 was performed by measuring repeatability and interassay, interbatch, and interlaboratory reproducibility. Results When measured globally (detection by 1 or more allergen components), ALEX2 had adequate sensitivity and specificity for most of the allergens studied, comparable in general with that of ISAC112 (except for olive pollen and walnut) and similar to that of ImmunoCAP whole extract measurements. Component-by-component analysis revealed comparable results for all techniques, except for Ole e 1 and Jug r 3, in both ISAC112 and ImmunoCAP comparisons, and Alt a 1, when compared with ISAC112. Continuous sIgE levels correlate with sIgE by ImmunoCAP. Good reproducibility and repeatability were observed for ALEX2. Conclusion ALEX2 has sound technical performance and adequate diagnostic capacity, comparable in general with that of ISAC112 and ImmunoCAP.

Files in This Item:
Quan PL 2022 AAAI.pdf
544.05 kB
Adobe PDF

Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.